ONCY
Oncolytics Biotech
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Oncolytics Biotech provides an update on clinical data from the GOBLET study and the final payment under its PanCAN grantOct 14, 2026
- Oncolytics Biotech secures patent protection extending into the late 2040s and updates its intellectual property portfolioOct 12, 2026
- Oncolytics Biotech publishes findings showing pelareorep generates immune responses in liver cancer that increase tumor susceptibility to immunotherapySep 30, 2026
- Oncolytics Biotech reports accelerating enrollment in the randomized REO 033 study in RAS-mutant, MSS colorectal cancerSep 29, 2026
- Oncolytics Biotech reported positive preclinical results combining pelareorep with a pan-RAS inhibitor in colorectal cancerSep 10, 2026